Skip to main content
SpringerLink
Log in

Isradipine in Patients with Acute Ischaemic Cerebral Infarction

An Overview of the ASCLEPIOS Programme

  • Section 3: Future Clinical Trends
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Calcium-related mechanisms are an integral part of metabolic reactions during acute cerebral infarction. In an animal model of stroke, the calcium antagonist isradipine was shown to protect neurons against ischaemia. In order to improve the neurological and functional outcome of human stroke patients, a randomised, double-blind, placebo-controlled multicentre study was started in up to 600 patients with acute ischaemic brain infarction. Since early treatment is considered to be of great importance, patients must be recruited no more than 12 hours after stroke onset. Medical, ECG, laboratory, neurological and functional evaluations are conducted for up to 90 days after stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adelman SM. The national survey of stroke/economic impact. Stroke 12: 169–187, 1981

    Google Scholar 

  • Constant P, Revou AM, Caille JM, Verhiet J, Dop A, et al. Aspects and evolution of cerebrovascular accidents. Journal of Neuroradiology 4: 291–310, 1977

    CAS  Google Scholar 

  • Gaab MR, Brawanski A, Bockhorn J. Calcium antagonism: a new therapeutic principle in stroke and vasospasm. Cerebral Blood Flow Bulletin 3: 47, 1982

    Google Scholar 

  • Gelmers HJ. Effect of nimodipine (BAY e 9736) on postischemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF). Acta Neurochirurgica (Wien) 63: 283–290, 1982

    Article  CAS  Google Scholar 

  • Gelmers HJ, Gorter K, de Weerdt CJ. A controlled trial of nimodipine in acute ischemic stroke. New England Journal of Medicine 318: 203–207, 1988

    Article  PubMed  CAS  Google Scholar 

  • Genton E, Barnett HJM, Fields WS. Cerebral ischemia: the role of thrombosis and antithrombotic therapy. Stroke 8: 150–175, 1977

    Article  PubMed  CAS  Google Scholar 

  • Hass WK, Easton JD, Adams HP. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Stroke 321: 501–507, 1989

    CAS  Google Scholar 

  • Herman B, Leyten ACM, van Luijk JH. Epidemiology of stroke in Tilburg, The Netherlands. Stroke 13: 629–634, 1982

    Article  PubMed  CAS  Google Scholar 

  • Hinds CJ. Prevention and treatment of brain ischemia. British Medical Journal 291: 758–760, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hsu CY, Faught RE, Furlan AJ. Intravenous prostacyclin in acute nonhemorrhagic stroke. Stroke 18: 352–358, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kurtzke JF. Epidemiology of cerebrovascular disease. In McDowell F, Caplan LR (Eds) Cerebrovascular study report. National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, 1985

    Google Scholar 

  • Mahoney FI, Barthel DW. Functional evaluation: Barthel index. Maryland State Medical Journal 14: 61–65, 1965

    PubMed  CAS  Google Scholar 

  • Marquardsen J. Epidemiology of stroke in Europe. In Barnett HJM, Mohr JP, Stein BM (Eds) Stroke: pathophysiology, diagnosis and management. Churchill-Livingstone, New York, 1985

    Google Scholar 

  • Martin JF, Handy N, Nicholl J. Double-blind controlled trial of prostacyclin in cerebral infarction. Stroke 16: 386–390, 1986

    Article  Google Scholar 

  • Orgogozo JM, Capildeo R. Methodology of clinical trials in stroke. In Capildeo R, Orgogozo JM (Eds) Methods in clinical trials in neurology, p. 140, MacMillan, London, 1988

    Google Scholar 

  • Orgogozo JM, Dartigues JF, Anagnostou CN. Mise au point d’un score neurologique pour l’évaluation clinique des infarctus sylviens. Nouvelle Presse Médicale 12: 3039–3044, 1983

    CAS  Google Scholar 

  • Sauter A. Calcium antagonists reduce the extent of infarction in a rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. Stroke 17: 1228–1234, 1986

    Article  PubMed  CAS  Google Scholar 

  • Sauter A, Rudin M, Wiederhold KH. Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists. Neurochemical Pathology 9: 212–236, 1988

    Google Scholar 

  • Schanne FA, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: a final common pathway. Science 206: 700–702, 1979

    Article  PubMed  CAS  Google Scholar 

  • Siesjö BK, Wieloch T. Molecular mechanisms of ischemic brain damage. In Plum F, Pulsinelli W (Eds) Cerebrovascular disorders. Raven Press, New York, 1985

    Google Scholar 

  • Simon RP, Griffiths T, McEvans JH, Swan S, Meldrum B. Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia on electron microscopy study in the rat. Journal of Cerebral Blood Flow Metabolism 4: 350–361, 1984

    Article  PubMed  CAS  Google Scholar 

  • Sivenius J. Studies on the rehabilitation, epidemiology and clinical features of stroke in East Central Finland. Academic dissertation, University of Kuopio, 1982

  • Sørensen PS, Boysen G, Jensen G. Prevalence of stroke in a district of Copenhagen. Acta Neurologica Scandinavica 66: 68–81, 1982

    Article  PubMed  Google Scholar 

  • Whitehead J. The design and analysis of sequential clinical trials. Ellis Horwood, Chichester, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CNS Department, Clinical Research, Sandoz Pharma Ltd, Basle, Switzerland

    A. Azcona &  X. Lataste

Authors
  1. A. Azcona
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Lataste
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

For a list of investigators in the ASCLEPIOS Study see p. 51.

We regret that Dr Azcona died recently.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azcona, A., Lataste, X. Isradipine in Patients with Acute Ischaemic Cerebral Infarction. Drugs 40 (Suppl 2), 52–57 (1990). https://doi.org/10.2165/00003495-199000402-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199000402-00013

Search

Navigation